Amid Biotech Pitfalls, ImmunityBio Has Outperformed NVDA In The Last 3 Months By: TalkMarkets May 13, 2024 at 15:00 PM EDT In the last three months, IBRX outperformed NVDA by over 3x. Read More >> Related Stocks: Immunitybio Inc Legend Biotech Corp ADR